YONGYUE(SH:603879)2019-10-30 16:00Financial Performance - Net profit attributable to shareholders decreased by 40.53% to CNY 20,280,955.01 for the first nine months of the year[6]. - Operating revenue for the first nine months decreased by 29.89% to CNY 313,415,643.33 compared to the same period last year[6]. - Basic earnings per share decreased by 41.18% to CNY 0.10[7]. - Revenue for the third quarter was ¥313,415,643.33, a decrease of 29.89% compared to the same period last year, attributed to lower sales volume and price declines in the chemical industry[15]. - Total operating revenue for Q3 2019 was ¥104,056,703.71, a decrease of 43.2% compared to ¥183,109,168.45 in Q3 2018[29]. - Net profit for Q3 2019 was ¥7,087,895.59, a decline of 45.0% from ¥12,924,567.97 in Q3 2018[31]. - The company’s total profit for Q3 2019 was CNY 7,549,440.62, a decrease of 43.5% from CNY 13,432,683.69 in Q3 2018[36]. Assets and Liabilities - Total assets decreased by 5.97% to CNY 564,448,998.29 compared to the end of the previous year[6]. - Current assets decreased from RMB 526,786,397.63 on December 31, 2018, to RMB 478,191,418.63 on September 30, 2019, a decline of approximately 9.2%[19]. - Total liabilities decreased from RMB 63,308,298.73 on September 30, 2018, to RMB 43,287,416.77 on September 30, 2019, a decrease of approximately 31.6%[22]. - The company's total equity decreased from RMB 536,959,564.91 on December 31, 2018, to RMB 521,161,581.52 on September 30, 2019, a decline of approximately 2.5%[22]. - Total assets decreased from ¥611,884,476.69 in Q3 2018 to ¥575,206,437.32 in Q3 2019, a reduction of 6.0%[27]. - Total liabilities decreased from ¥71,258,253.19 in Q3 2018 to ¥51,069,801.13 in Q3 2019, a decline of 28.4%[27]. Cash Flow - Net cash flow from operating activities was negative at CNY -11,231,108.98 for the first nine months[6]. - The net cash flow from operating activities was -¥11,231,108.98, an improvement from -¥55,440,726.14 in the previous year[15]. - Cash inflow from operating activities totaled CNY 333,635,229.95, a decrease of 28.2% compared to CNY 464,123,713.47 in the previous year[43]. - Net cash flow from operating activities was negative at CNY -10,657,697.44, improving from CNY -54,645,009.01 year-over-year[43]. - Cash inflow from investment activities was CNY 474,042,109.59, slightly down from CNY 477,914,763.14 in the previous year[43]. - Net cash flow from investment activities was CNY 4,116,341.18, a significant decrease of 93.4% compared to CNY 62,481,666.35 in the previous year[43]. Shareholder Information - The total number of shareholders at the end of the reporting period was 8,363[11]. - The largest shareholder, Fu Wenchang, holds 20.96% of the shares, with 42,000,000 shares pledged[11]. Government Support and Investments - The company received government subsidies amounting to CNY 2,298,890.00 during the reporting period[8]. - The company has invested in long-term equity investments amounting to RMB 47,438,524.00 as of September 30, 2019, compared to RMB 33,138,124.00 in the previous year, an increase of approximately 43.3%[25]. Research and Development - Research and development expenses fell by 36.34% to ¥9,668,701.70, reflecting reduced investment due to lower material prices[15]. - Research and development expenses for Q3 2019 were ¥3,350,364.40, a decrease of 46.7% from ¥6,296,378.44 in Q3 2018[30]. - Research and development expenses for the first three quarters of 2019 totaled CNY 9,668,701.70, a decline of 36.5% from CNY 15,188,114.31 in the same period of 2018[35]. Outlook and Market Conditions - The company anticipates potential losses or significant changes in net profit compared to the previous year, indicating a cautious outlook[16]. - The company has not disclosed any new product developments or market expansion strategies in this report[6].